The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers.
about
Probiotics for treating acute infectious diarrhoeaRole and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An updateThe Dynamic Interactions between Salmonella and the Microbiota, within the Challenging Niche of the Gastrointestinal TractEscherichia coli Nissle 1917 enhances bioavailability of serotonin in gut tissues through modulation of synthesis and clearance.Insights from 100 Years of Research with Probiotic E. ColiAdministration of a probiotic can change drug pharmacokinetics: effect of E. coli Nissle 1917 on amidarone absorption in ratsProbiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrityUse of Wild Type or Recombinant Lactic Acid Bacteria as an Alternative Treatment for Gastrointestinal Inflammatory Diseases: A Focus on Inflammatory Bowel Diseases and Mucositis.Are probiotics a feasible intervention for prevention of diarrhoea in the developing world?Clinical use of E. coli Nissle 1917 in inflammatory bowel disease.Disruption of Escherichia coli Nissle 1917 K5 capsule biosynthesis, through loss of distinct kfi genes, modulates interaction with intestinal epithelial cells and impact on cell health.A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndromeDifferential Effects of Escherichia coli Nissle and Lactobacillus rhamnosus Strain GG on Human Rotavirus Binding, Infection, and B Cell Immunity.High protective efficacy of rice bran against human rotavirus diarrhea via enhancing probiotic growth, gut barrier function, and innate immunityHigh Protective Efficacy of Probiotics and Rice Bran against Human Norovirus Infection and Diarrhea in Gnotobiotic Pigs.Escherichia coli Nissle 1917 targets and restrains mouse B16 melanoma and 4T1 breast tumors through expression of azurin protein.Probiotics: properties, examples, and specific applications.Effects of probiotics in patients with diabetes mellitus type 2: study protocol for a randomized, double-blind, placebo-controlled trial.Probiotics in clinical practice: an overview.The use of probiotic strains in caries prevention: a systematic review.Probiotic bacteria reduce salmonella typhimurium intestinal colonization by competing for iron.The dual role of bacteriocins as anti- and probiotics.Pro-inflammatory potential of Escherichia coli strains K12 and Nissle 1917 in a murine model of acute ileitis.Impact of metal ion homeostasis of genetically modified Escherichia coli Nissle 1917 and K12 (W3110) strains on colonization properties in the murine intestinal tract.Persistence of colicinogenic Escherichia coli in the mouse gastrointestinal tract.Indications for the use of probiotics in gastrointestinal diseases.Escherichia coli Nissle 1917 (Mutaflor): new insights into an old probiotic bacterium.The role of probiotics and prebiotics in inducing gut immunity.A systematic review of the safety of probiotics.Interleukin-8, CXCL1, and MicroRNA miR-146a Responses to Probiotic Escherichia coli Nissle 1917 and Enteropathogenic E. coli in Human Intestinal Epithelial T84 and Monocytic THP-1 Cells after Apical or Basolateral Infection.Escherichia coli strain Nissle 1917-from bench to bedside and back: history of a special Escherichia coli strain with probiotic properties.Unraveling the Differences between Gram-Positive and Gram-Negative Probiotics in Modulating Protective Immunity to Enteric Infections.[Microbiota and probiotics: effects on human health].Rethinking the composition of a rational antibiotic arsenal for the 21st century.The K5 capsule of Escherichia coli strain Nissle 1917 is important in stimulating expression of Toll-like receptor 5, CD14, MyD88, and TRIF together with the induction of interleukin-8 expression via the mitogen-activated protein kinase pathway in eThe probiotic Escherichia coli Nissle 1917 inhibits propagating colonic contractions in the rat isolated large intestine.Practical approaches to probiotics use.The K5 capsule of Escherichia coli strain Nissle 1917 is important in mediating interactions with intestinal epithelial cells and chemokine induction.An adherent mucus layer attenuates the genotoxic effect of colibactin.Scientific Opinion on the maintenance of the list of QPS microorganisms intentionally added to food or feed (2009 update)
P2860
Q24236704-A5E52D67-012E-497D-80B0-4CC8470754A8Q26746916-4AB77C2B-E8D1-44DF-916C-AD02312B0C09Q27010010-D2701CF3-9F23-4997-9434-8FE9A6CB3484Q27304899-0CBC98FA-B14F-45A1-ACF0-37A401027A27Q28079219-2F7C2A8C-41E9-4753-B097-8E7054408C6EQ28539513-D7B84E9F-A4EF-45CB-8C3F-2BB4F521D4D2Q33309955-FE6D9A87-E3C3-4D7A-9161-E580323D6745Q33650357-DECAB2F7-FF00-464B-8185-B05EE9E133C2Q34133531-A630B8F1-43E6-4A62-B2E5-067D46A093E3Q34744012-F86A98AF-7348-43FD-AB1C-341F7EEA37F2Q35581546-CA761268-7C05-4BEB-B1FA-F74A48050EADQ35840560-FDC747ED-8E8B-493D-BC90-89555ACE3DC9Q35901914-A08C0B14-EA5E-4843-8902-605C097C2EC6Q36149919-28EED535-5391-489D-AAEA-1011C6A5202BQ36194784-F6AF0721-D28A-4AAA-A42F-478B348E262BQ36361827-8BFAB441-F601-4758-A9CC-FB9764DF8C91Q36629073-0F20A1B0-8070-4C31-886C-554B979EED5EQ37004077-038E078D-D786-4EB6-98CC-C962477A896AQ37071265-D0211FCD-482E-45FD-A38D-6AFE57C30306Q37083793-D49F12DD-3F9E-464A-9EC5-1695390C551BQ37118020-0B7AC9A1-057A-4AC0-82B1-D757C23174AEQ37160785-BE8DA6B4-B229-467E-9C9F-25D6B0E80D5FQ37320010-89F9180F-49F1-4DD9-8496-B7752178CDB5Q37320020-43DF6423-B9FB-47D0-8453-671DF0FF6FBEQ37341276-7AA4EDAF-B41A-46A7-AF05-8191B8492FB5Q37969593-3D612271-B7AE-47FA-8CB3-07ACAA407E30Q37969596-15207190-C0EC-40D9-A0A8-12CE31DF10CAQ38174603-F4F0C50D-308B-4ED3-A2EF-BC26137C3F56Q38176954-F0C6FE2C-1E06-4C16-8797-B4062CDD528FQ38764707-95712705-9DA8-438E-9A0D-D6D3A55B66B8Q38952390-71BD15A0-CFC4-4B96-B496-83CF0A52D866Q39233059-BE1D4933-317C-4FD6-B120-899938CDABD2Q39281119-CEC36A10-7B85-4BBD-9439-13F36762314AQ39383695-01E01D38-5130-496F-8DD1-9A7AE502DCB8Q39741559-E2C8E668-2553-466D-99C5-BF93B083B827Q41653055-48AE45AD-2B8B-44BC-90AC-BD79D843562BQ42216604-88DEB0F5-BFAB-4992-8203-1D550AFA647CQ43097032-E10EEE72-A711-4052-A87B-E29B40F792FBQ46257981-E388F8C7-59E0-46F4-8894-4DC1A7EEB39FQ47147789-0307B820-3FCB-4B90-9580-41D54AB4FC5C
P2860
The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The probiotic Escherichia coli ...... rhoea in infants and toddlers.
@ast
The probiotic Escherichia coli ...... rhoea in infants and toddlers.
@en
type
label
The probiotic Escherichia coli ...... rhoea in infants and toddlers.
@ast
The probiotic Escherichia coli ...... rhoea in infants and toddlers.
@en
prefLabel
The probiotic Escherichia coli ...... rhoea in infants and toddlers.
@ast
The probiotic Escherichia coli ...... rhoea in infants and toddlers.
@en
P2093
P2860
P1476
The probiotic Escherichia coli ...... rhoea in infants and toddlers.
@en
P2093
Boris M Blokhin
Corinna Wolff
Jobst Henker
Jürgen Schulze
Martin Laass
Martina Elze
Vitaliy G Maydannik
Yuriy K Bolbot
P2860
P2888
P304
P356
10.1007/S00431-007-0419-X
P577
2007-02-08T00:00:00Z